April 17th 2025
The positive topline data from the phase 3 ACHIEVE-1 trial suggest the small molecule GLP-1 mimetic could compete with blockbuster weekly injectables for reducing weight, A1c.
A Judgment on Heart Benefits of Best-Selling Diets
October 1st 2007WORCESTER, Mass. -- In a collision of the best-selling weight-loss books, the neovegetarian fare pushed by the Ornish diet earned heart-healthy honors, according to the standards of an index that dices the risks of fats and carbohydrates.